KR20090091898A - Oral compositions containing luffa cylindrica - Google Patents
Oral compositions containing luffa cylindricaInfo
- Publication number
- KR20090091898A KR20090091898A KR1020080017109A KR20080017109A KR20090091898A KR 20090091898 A KR20090091898 A KR 20090091898A KR 1020080017109 A KR1020080017109 A KR 1020080017109A KR 20080017109 A KR20080017109 A KR 20080017109A KR 20090091898 A KR20090091898 A KR 20090091898A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- cucumber
- scrubber
- oral cavity
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 235000009814 Luffa aegyptiaca Nutrition 0.000 title claims description 17
- 244000302544 Luffa aegyptiaca Species 0.000 title description 16
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 39
- 210000000214 mouth Anatomy 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 28
- 240000008067 Cucumis sativus Species 0.000 claims description 40
- 239000000606 toothpaste Substances 0.000 claims description 22
- 229940034610 toothpaste Drugs 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000002324 mouth wash Substances 0.000 claims description 13
- 229940051866 mouthwash Drugs 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 10
- 239000011230 binding agent Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000004088 foaming agent Substances 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000003906 humectant Substances 0.000 claims description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 244000280244 Luffa acutangula Species 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 abstract description 14
- 230000004054 inflammatory process Effects 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 238000009499 grossing Methods 0.000 abstract description 2
- 244000299906 Cucumis sativus var. sativus Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- -1 etc.) Chemical compound 0.000 description 5
- 210000004195 gingiva Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000009849 Cucumis sativus Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000019691 monocalcium phosphate Nutrition 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 238000009991 scouring Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- ZAUYNCUCMJDAHW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;hydrogen peroxide;molecular iodine Chemical compound OO.II.C=CN1CCCC1=O ZAUYNCUCMJDAHW-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-UHFFFAOYSA-N 2-aminohexanoic acid Chemical compound CCCCC(N)C(O)=O LRQKBLKVPFOOQJ-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 240000008025 Alternanthera ficoidea Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000034619 Gingival inflammation Diseases 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000331120 Krameria cistoidea Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000012420 sanguinaria Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 수세미오이의 절편 또는 추출물, 또는 이들 모두를 함유하는 구강용 조성물에 관한 것으로, 이에 의하여 잇몸 내 혈류를 원활히 하고 소염 및 항균활성에 의해 구강염증을 예방 및 완화할 수 있다.The present invention relates to a composition for oral cavity containing slices or extracts of scrubber cucumber, or both, thereby smoothing blood flow in the gums and preventing and alleviating oral inflammation by anti-inflammatory and antibacterial activity.
Description
본 발명은 수세미오이의 절편 또는 추출물, 또는 이들 모두를 함유하는 구강용 조성물에 관한 것이다.The present invention relates to compositions for oral cavity containing fragments or extracts of scrubber cucumber, or both.
수세미(Luffa cylindrical)는 박과의 1년생 덩굴성 식물로 수세미외, 사과, 수과락, 수과, 만과, 천락사(天絡絲) 또는 천라(天羅) 라고도 한다. 줄기는 갈라지며 덩굴손을 내어 다른 물체를 감으면서 올라간다. 잎은 손바닥 모양으로 오이잎과 비슷한 모양으로 어긋나며 꽃은 7~10월에 달린다. 수꽃은 각 앞 겨드랑이에 여러 개가 모여 피고, 암꽃은 잎겨드랑이에 1개씩 핀다. 열매는 10월에 익는데, 길이 30㎝~70㎝ 정도로 오이처럼 처음에는 녹색이다가 익으면 노랗게 변하며 겉에 세로로 얕은 골이 진다. Lumpa cylindrical is a vine-like plant of annual fruit, also known as loofah, apple, hydrangea, aquatic plant, gulf, cheonraksa (天 絡 絲) or cheonra (天 羅). The stalk splits and lifts up with tendrils to wind up other objects. Leaves are palm-shaped, similar to cucumber leaves, and flowers run from July to October. A male flower blooms in front of each armpit, and a female flower blooms in leaf axle. Fruits ripen in October, about 30㎝ ~ 70㎝ long, like green cucumbers, and then green when ripe.
어린 열매는 식용으로 사용하고 성숙한 섬유는 주로 철도차량의 차축급유의 버트, 선박기관과 갑판의 세척용, 신 바닥의 깔개, 여성용 모자의 속, 슬리퍼, 바구니 등을 만드는 데 쓰인다. 이 섬유질조직을 수세미로 이용한 데서 열매의 이름도 비롯되었다. Young fruits are used for food, and mature fibers are mainly used to make axles for axles of railroad cars, to wash ships and decks, to rug bottoms, to cover women's hats, slippers and baskets. The name of the fruit comes from the use of this fibrous tissue as a loofah.
지금까지 밝혀진 수세미 성분은, 각종 세포에 영양소를 공급하며 삼투압을 조절하는 회분, 열을 내리고 해독작용을 하는 카로틴, 면역작용과 혈액의 생성과 정혈작용도 하는 단백질이 들어 있다고 한다. 이 밖에도 식이섬유, 칼슘, 칼륨, 철, 마그네슘, 필수 아미노산 등 다양한 성분이 들어 있다. The scrubber ingredient so far discovered contains nutrients that supply various cells to control osmotic pressure, carotene that lowers heat and detoxification, and protein that also plays a role in immune and blood production and blood circulation. In addition, it contains various ingredients such as dietary fiber, calcium, potassium, iron, magnesium, and essential amino acids.
수세미오이는 성질이 차서 몸에 열이 많아 생기는 가래를 삭히고. 뜨거운 피를 식혀줌으로써 혈액순환을 촉진시키고 소염작용을 하며, 변비, 축농증 증상을 치료하는데 도움이 된다. 또한 수세미씨와 잎은 이뇨작용과 해독작용이 있으며, 껍질과 뿌리는 진통 소염작용을 한다고 알려져 있다. 수세미오이 줄기의 절단면에서 나오는 수액은 식용이 가능하며 화장품의 원료로 쓰이기도 한다.Scrub cucumbers are so tender that they cut off phlegm that causes a lot of heat in your body. By cooling hot blood, it promotes blood circulation, anti-inflammatory, and helps to treat constipation and sinusitis. In addition, scrubber seeds and leaves have a diuretic and detoxification effect, the skin and roots are known to have analgesic anti-inflammatory action. The sap coming from the cut surface of the stem of the loofah is edible and also used as a raw material for cosmetics.
한편, 기존의 구강용 조성물에 잇몸 염증 예방 또는 완화를 위하여 아미노카프론산, 비타민 E 아세테이트(초산토코페롤), 알란토인 및 그 유도체, 트라넥사민산, 소금, 염산피리독신(비타민B6) 등이 사용되었다. 또한, 수천년간 민간에서 널리 사용되어져 왔으며 구강질환의 원인균에 효과가 있는 것으로 알려진 생귀나리아(Sanguinaria) 추출물(미국 등록특허 제4,689,216호), 몰약(Myrrh), 라타니(Rhatany), 세이지(Sage), 카모밀레(Chamomile), 에치네시아(Echinacea) 등의 추출물(S.deRysky; Journal of Clinical Dentistry Vol.I, Supplement A. A22-24,1988), 세이지(Sage) 및 미질향(Rosemary) 등의 추출물(일본 공개특허공보 소58-134013호), 홉(Hops) 추출물(일본국 공개특허공보 소62-138420호) 등의 약용식물의 추출물이 잇몸 염증 예방 또는 완화를 위하여 사용되었다. 그러나 이들 소재로서 잇몸 염증 예방 또는 완화 효과를 충분히 달성하기 어려웠고, 또한 일부 소재의 경우 구강용 조성물의 제형 중 치약 제형에 있어서 치약 상태에 대한 안정성의 변화를 야기시켜 효능효과를 나타내기에 충분한 양을 적용하기 어려운 점이 있었다.Meanwhile, aminocaproic acid, vitamin E acetate (tocopherol acetate), allantoin and its derivatives, tranexamic acid, salt, pyridoxine (vitamin B6), and the like have been used for preventing or alleviating gum inflammation in existing oral compositions. In addition, Sanguinaria extract (US Pat. No. 4,689,216), Myrrh, Rhatany, Sage (Sage), which has been widely used in the private sector for thousands of years and is known to be effective in causing diseases of oral diseases. ), Extracts of chamomile, Echinacea (S.deRysky; Journal of Clinical Dentistry Vol.I, Supplement A. A22-24,1988), Sage and Rosemary Extracts of medicinal plants such as extracts (Japanese Patent Laid-Open No. 58-134013) and Hops extract (Japanese Patent Laid-Open No. 62-138420) were used for preventing or alleviating gum inflammation. However, as these materials, it was difficult to sufficiently achieve the effect of preventing or alleviating gum inflammation, and in some cases, an amount sufficient to exhibit efficacy by causing a change in the stability of the toothpaste in the toothpaste formulation in the formulation of the oral composition was applied. There was something difficult to do.
이에 본 발명자들은 구강 염증 완화에 우수한 효과를 가지고 있으면서도 잇몸 내 혈류량을 촉진시켜 구강 염증의 예방에도 우수한 효과를 나타낼 수 있는 소재를 연구한 결과, 지금까지 치약을 비롯한 구강제품에 수세미오이의 절편 또는 추출물, 또는 이들 모두를 직접 적용한 적이 없음에도 이들 수세미오이의 절편 및/또는 추출물이 상기와 같은 효과를 가짐을 발견하고 본 발명을 완성하였다.Accordingly, the present inventors studied a material that has an excellent effect on relieving oral inflammation and promotes blood flow in the gums and shows an excellent effect on the prevention of oral inflammation. Thus, slices or extracts of scrubbers in oral products including toothpaste have been studied. Although no direct or all of these have been applied directly, the fragments and / or extracts of these scrubbers have been found to have the same effect and have completed the present invention.
본 발명의 하나의 목적은 수세미오이의 절편 또는 추출물, 또는 이들 모두를 함유하는 구강용 조성물을 제공하는 것이다.One object of the present invention is to provide a composition for oral cavity containing fragments or extracts of scrubber cucumber, or both.
본 발명의 다른 하나의 목적은 상기 구강용 조성물을 포함하는 제형으로서, 치약, 구강용세정제 및 구강청정제 등을 제공하는 것이다.Another object of the present invention as a formulation comprising the composition for oral cavity, to provide a toothpaste, mouthwash and mouthwash.
하나의 양태로서, 본 발명은 수세미오이의 절편 또는 추출물, 또는 이들 모두를 함유하는 구강용 조성물에 관한 것이다.In one embodiment, the present invention relates to a composition for oral cavity containing fragments or extracts of scrubber cucumber, or both.
본 발명의 수세미오이는 박과의 1년생 덩굴성 식물로서, 수세미외, 사과, 수과락, 수과, 만과, 천락사(天絡絲), 천라(天羅) 또는 수세미라고도 통칭되는 식물을 말한다. 본 발명의 수세미오이의 절편 및 추출물은 수세미오이의 뿌리, 줄기, 잎, 껍질, 섬유질 등의 모든 부분으로부터 유래하며, 수세미오이의 일부분에 한정되지 않는다.The loofah cucumber of the present invention is a vine-like plant of annual fruit, and refers to a plant also known as loofah, apple, hydrangea, achene, gulf, cheonraksa, cheonra or loofah. Sections and extracts of the scrubber cucumber of the present invention are derived from all parts of the root, stem, leaves, shells, fibers and the like of the scrubber cucumber, and are not limited to a part of the scrubber cucumber.
본 발명의 수세미오이의 절편은 수세미오이를 1 내지 6㎜의 크기로 잘게 분쇄한 것으로 분말 형태보다는 크기가 큰 분쇄물을 말한다. 상기 수세미오이의 절편이 1mm보다 작을 경우 물리적인 잇몸 마사지 효과를 기대할 수 없고, 6mm이상으로 너무 클 경우 수세미오이의 함량에 비해 혼입되는 절편의 수가 적어지는 문제가 있어 바람직하지 않다. 상기 수세미오이의 절편은 본 발명의 구강용 조성물의 총 중량을 기준으로 0.05내지 10중량%, 바람직하게는 0.1 내지 6중량%, 보다 바람직하게는 0.5 내지 5중량% 함유된다. 상기 수세미오이의 절편의 함량이 0.05 중량% 미만인 경우는 그 효과가 미약하고, 10중량% 보다 높으면 조성물의 성상 및 안정성이 좋지 못할 뿐 아니라, 효과 상승에 비하여 비용이 지나치게 높아지는 문제점이 있다.The slice of the scrubber cucumber of the present invention is a finely crushed scrubber cucumber 1 to 6 mm in size refers to a larger size than the powder form. When the slices of the scrubber cucumber is smaller than 1 mm, physical gum massage effects cannot be expected, and when the slices of the scrubber cucumber are larger than 6 mm, there is a problem in that the number of the pieces to be mixed is less than that of the scrubber cucumber. The slices of the scrubber cucumber are contained in an amount of 0.05 to 10% by weight, preferably 0.1 to 6% by weight, more preferably 0.5 to 5% by weight, based on the total weight of the composition for oral cavity of the present invention. When the content of the slices of the scrubber cucumber is less than 0.05% by weight, the effect is weak, if higher than 10% by weight, the composition and the stability of the composition is not good, there is a problem that the cost is too high compared to the increase in effect.
본 발명의 수세미오이의 추출물은 당해 분야에 알려진 추출물의 제조방법에 의하여 제조할 수 있다. 즉, 수세미 전초를 건조하고 세단한 후, 용매, 바람직하게는 물, 정제수 혹은 저급알콜, 노말헥산 및 1,3-부틸렌글리콜로 이루어진 군으로부터 하나 이상 선택된 용매로 추출하여 얻는다. 보다 구체적으로, 수세미오이를 통상적인 방법에 따라 물 또는 정제수 등으로 세정한 후, 동결건조, 자연건조 또는 열풍건조 등의 건조 처리를 통상적인 방법에 따라 수행한다. 이후, 건조 처리된 수세미오이를 세단한 후, 물, 정제수, 저급알콜(예를 들면, 에탄올, 메탄올, 부탄올 등), 노말헥산 또는 1,3-부틸렌글리콜 등이 1종 이상 혼합된 용매 500ml에 수세미 50g을 3일간 침적 추출 여과한 후 감압 농축시켜 본 발명의 수세미오이의 추출물을 제조할 수 있다.The extract of scrubber cucumber of the present invention can be prepared by a method for preparing an extract known in the art. That is, the scouring pad is dried and rinsed, and then extracted with a solvent, preferably water, purified water or one or more solvents selected from the group consisting of lower alcohols, normal hexane and 1,3-butylene glycol. More specifically, after washing the scrubber with water or purified water according to a conventional method, the drying treatment such as lyophilization, natural drying or hot air drying is performed according to a conventional method. Subsequently, after washing the dried scrubber cucumber, 500 ml of a solvent mixed with at least one of water, purified water, lower alcohol (for example, ethanol, methanol, butanol, etc.), normal hexane, 1,3-butylene glycol, and the like 50 g of scrubbers were immersed and filtered for 3 days, and then concentrated under reduced pressure to prepare an extract of scrubber cucumber of the present invention.
상기 수세미오이의 추출물은 본 발명의 구강용 조성물의 총 중량에서 0.01 내지 2중량%, 바람직하게는 0.05 내지 2 중량% 함유된다. 상기 수세미오이의 추출물 함량이 0.01 중량% 미만인 농도에서는 치은염증에 대한 효능 및 효과를 기대할 수 없고, 2.0 중량%를 초과할 경우에는 제품의 안정성 저하로 부적합하다.The extract of the scrubber cucumber is contained 0.01 to 2% by weight, preferably 0.05 to 2% by weight in the total weight of the composition for oral cavity of the present invention. At a concentration of less than 0.01% by weight of the extract content of the scrubber cucumber can not expect efficacy and effects on gingival inflammation, when exceeding 2.0% by weight is unsuitable for the stability of the product.
본 발명의 구강용 조성물은 수세미오이의 절편 또는 수세미오이의 추출물의 각각을 함유할 수 있으며, 또는 수세미오이의 절편 및 수세미오이의 추출물을 모두 함유할 수 있다. 바람직하게는 본 발명의 구강용 조성물은 수세미오이의 절편 및 수세미오이의 추출물을 모두 함유한다. 상기 수세미오이의 절편 및 수세미오이의 추출물을 모두 함유하는 경우 상기 수세미오이의 절편 또는 수세미오이의 추출물의 각각의 함량 내에서 적절한 비율로 본 발명의 구강용 조성물에 함유된다.The composition for oral cavity of the present invention may contain each of the slices of the loofah cucumber or the extract of the loofah cucumber, or may contain both the slices of the loofah and cucumber extract. Preferably, the composition for oral cavity of the present invention contains both a slice of scrubber and an extract of scrubber. When both the fragment of the loofah cucumber and the extract of the loofah cucumber are contained in the composition for oral cavity of the present invention in an appropriate ratio within each content of the fragment of the loofah cucumber or the extract of the loofah cucumber.
본 발명에 따른 구강용 조성물은 잇몸 마사지 효과에 의한 잇몸 내 혈류를 원활히 하고, 소염 및 항균작용에 의한 잇몸 염증의 예방 및 완화시키는데 효과가 있다. 이러한 효과는 본 명세서의 효과시험예의 임상적 실험을 통해 알 수 있는데, 이는 본 발명의 구강용 조성물이 잇몸의 물리적 마사지에 의해 혈류를 원활히 하고 수세미 성분 중의 항균 성분에 의한 소염 및 항균효과 등에 의해 잇몸 염증을 예방, 완화할 수 있음을 의미한다. The composition for oral cavity according to the present invention is effective in smoothing the blood flow in the gum by the gum massage effect, and preventing and alleviating the inflammation of the gum by anti-inflammatory and antibacterial action. This effect can be seen through the clinical experiment of the effect test example of the present specification, which is a composition for the oral cavity of the present invention to smooth the blood flow by physical massage of the gums and gums due to anti-inflammatory and antibacterial effect by the antibacterial component in the scrubber component It means that inflammation can be prevented and alleviated.
본 발명에 따른 구강용 조성물에 함유된 수세미오이의 절편 및 수세미오이의 추출물은 식용 가능한 수세미오이로부터 유래한 것이므로 거의 독성이 없다. 따라서, 본 발명의 구강용 조성물은 인체에 무해하며, 안전하게 사용할 수 있다.The fragments of the scrubber cucumber and the extract of scrubber cucumber contained in the composition for oral cavity according to the present invention are derived from the edible scrubber cucumber and are therefore almost nontoxic. Therefore, the composition for oral cavity of this invention is harmless to a human body, and can be used safely.
본 발명에 의한 구강용 조성물은 그 제형에 있어서 특별히 한정되지 않으며, 구체적인 예로는 치약, 구강용 세정제, 구강용 청정제, 껌, 캔디류, 구강스프레이, 구강양치액 등의 제형을 가질 수 있다. The composition for oral cavity according to the present invention is not particularly limited in the formulation, and specific examples may include formulations such as toothpaste, mouthwash, mouthwash, gum, candy, oral spray, and mouthwash.
하나의 예로서, 본 발명의 구강용 조성물이 치약의 제형일 경우, 연마제, 습윤제, 결합제, 기포제, 감미제, pH 조절제, 방부제, 약효성분, 향료, 증백제, 색소, 용제 등을 함유할 수 있다. 또한, 상기 치약은 최종 상품의 제형 및 포장 형태로서 기존의 연고상(페이스트상)의 튜브에 적용될 수 있다. As an example, when the composition for oral cavity of the present invention is a toothpaste formulation, it may contain an abrasive, a humectant, a binder, a foaming agent, a sweetening agent, a pH adjusting agent, a preservative, an active ingredient, a fragrance, a brightener, a pigment, a solvent, and the like. . In addition, the toothpaste can be applied to the tube of the existing ointment (paste) in the form of formulation and packaging of the final product.
상기 연마제로는 침강 실리카, 실리카 겔, 지르코늄 실리케이트, 인산일수소칼슘, 무수 인산일수소칼슘, 함수 알루미나, 경질 탄산칼슘, 중질 탄산칼슘, 칼슘피로인산염, 불용성 메타인산염 및 알루미늄실리케이트 등을 들 수 있다. 상기 연마제 성분을 단독 또는 2 종 이상 혼합하여 조성물 총 중량에 대하여 5 내지 60 중량%로 첨가할 수 있다. 연마제의 입자 크기는 종류에 따라 다르지만, 평균 입자경이 20 ㎛ 이하인 것을 사용하는 것이 바람직하다. Examples of the abrasive include precipitated silica, silica gel, zirconium silicate, calcium dihydrogen phosphate, anhydrous calcium dihydrogen phosphate, hydrous alumina, hard calcium carbonate, heavy calcium carbonate, calcium pyrophosphate, insoluble metaphosphate and aluminum silicate. . The abrasive component may be added alone or in combination of two or more thereof in an amount of 5 to 60 wt% based on the total weight of the composition. Although the particle size of an abrasive | polishing agent changes with kinds, it is preferable to use the thing whose average particle diameter is 20 micrometers or less.
상기 습윤제는 연고상의 제형을 만드는데 필수적인 성분으로, 치약이 공기 중에 노출될 때 건조 고화되는 것을 방지하고 치약의 표면에 윤기를 제공할 뿐 아니라, 종류에 따라 양치시 감미를 주는 역할도 한다. 상기 습윤제로는 농글리세린(98%), 글리세린(85%), 소르비톨 수용액(70%), 비결정성 소르비톨 수용액(70%), 자이리톨, 폴리에틸렌글리콜류 및 프로필렌글리콜 등을 들 수 있으며, 상기 습윤제 성분을 단독 또는 2종 이상 혼합하여 조성물 총 중량에 대하여 40 내지 70 중량%로 첨가할 수 있다. The humectant is an essential ingredient in the preparation of the ointment formulation, it prevents dry solidification when the toothpaste is exposed to the air and gives a shine to the surface of the toothpaste, and also serves to sweeten the toothpaste depending on the type. Examples of the humectant include concentrated glycerin (98%), glycerin (85%), sorbitol aqueous solution (70%), amorphous sorbitol aqueous solution (70%), ziitol, polyethylene glycols and propylene glycol, and the like. May be added alone or in combination of two or more of 40 to 70% by weight based on the total weight of the composition.
상기 결합제는 고체인 분말 성분과 액체 성분이 분리되지 않게 해주는 역할을 하는 것으로, 연고상의 치약에서는 필수적인 성분이다. 결합제는 수용성 고분자 종류라면 어떤 것이나 사용 가능하고, 일반적으로 많이 사용되는 성분으로는 셀룰로오스로부터 유래된 카르복시메틸셀룰로오스 나트륨, 해조류로부터 추출된 카라기난류 및 미생물의 대사로부터 얻어지는 잔탄검 등을 들 수 있다. 상기 결합제 성분을 단독 또는 2종 이상 혼합하여 조성물 총 중량에 대하여 0.1 내지 5중량%, 바람직하게는 0.1 내지 2중량%로 첨가할 수 있다.The binder serves to prevent the solid powder and liquid components from being separated, and is essential in the ointment toothpaste. The binder can be used as long as it is a water-soluble polymer. Examples of commonly used components include sodium carboxymethyl cellulose derived from cellulose, carrageenan extracted from seaweed, and xanthan gum obtained from metabolism of microorganisms. The binder component alone or in combination of two or more thereof may be added in an amount of 0.1 to 5% by weight, preferably 0.1 to 2% by weight, based on the total weight of the composition.
상기 기포제는 제품의 사용감을 증진시키고 세정 작용을 도와주며 기타 약효성분의 분산 및 침투를 신속하게 하고 계면 장력을 감소시킴으로써, 구강내 이물질을 쉽게 떨어지게 하는 작용을 한다. 기포제로는 주로 음이온성 계면활성제인 라우릴황산나트륨이 사용되며, 제형의 특성에 따라 보조적으로 비이온성 계면활성제인 폴리옥시에틸렌폴리옥시프로필렌의 공중합체(폴록사머), 폴리옥시에틸렌경화피마자유, 폴리옥시에틸렌소르비탄 지방산에스테르 등이 사용될 수 있다. 상기 기포제 성분은 조성물의 총 중량에 대해 0.1 내지 2중량%로 첨가할 수 있다.The foaming agent acts to easily remove foreign substances in the oral cavity by enhancing the feeling of use of the product, aiding in the cleaning action, and speeding up the dispersion and penetration of other active ingredients and reducing the interfacial tension. As the foaming agent, sodium lauryl sulfate, an anionic surfactant, is mainly used.A copolymer of polyoxyethylene polyoxypropylene (polyoxamer), polyoxyethylene cured castor oil, poly Oxyethylene sorbitan fatty acid ester and the like can be used. The foaming agent component may be added at 0.1 to 2% by weight relative to the total weight of the composition.
상기 감미제로는 삭카린나트륨, 아스파탐, 스테비오사이드, 자일리톨, 감초산 등을 단독 또는 2종 이상 혼합하여 조성물 총 중량에 대하여 0.05 내지 5 중량% 사용할 수 있다.As the sweetener, saccharin sodium, aspartame, stevioside, xylitol, and licorice may be used alone or in combination of two or more, and may be used in an amount of 0.05 to 5 wt% based on the total weight of the composition.
상기 pH 조절제로는 인산나트륨, 인산이나트륨, 인산삼나트륨, 피로인산나트륨, 구연산나트륨, 구연산, 주석산 등이 있고, 상기 방부제로는 파라옥시안신향산메칠(메칠파라벤), 파라옥시안식향산프로필, 안식향산나트륨을 단독 또는 2종 이상 혼합하여 사용할 수 있다.The pH adjusting agent includes sodium phosphate, disodium phosphate, trisodium phosphate, sodium pyrophosphate, sodium citrate, citric acid, tartaric acid, and the like. The preservatives include methyl paraoxyanmic acid (methylparaben), propyl paraoxybenzoic acid, and benzoic acid. Sodium may be used alone or in combination of two or more thereof.
상기 약효 성분으로는 치아에 불소막을 형성하여 충치균의 대사산물인 산(젖산 등)에 강하게 만드는 불화물과, 치주 질환을 예방하기 위한 아미노카프론산, 알란토인 및 알란토인 유도체, 비타민류를 동시에 사용할 수 있으며, 구강내 유해 미생물의 번식을 억제하여 구강위생을 증진시킬 목적으로 트리클로산 등을 단독 또는 2종 이상 혼합하여 사용할 수 있다. As the active ingredient, a fluoride which forms a fluorine film on the teeth to be strong against acid (lactic acid), which is a metabolite of cavities, and aminocapronic acid, allantoin and allantoin derivatives and vitamins for preventing periodontal disease can be used simultaneously. Triclosan or the like may be used alone or in combination of two or more for the purpose of inhibiting the growth of harmful microorganisms in the oral cavity to promote oral hygiene.
상기 향료로는 페퍼민트오일, 스피아민트오일, 멘톨, 아네톨 등을 적당량 혼합하여 사용할 수 있으며, 상기 증백제로는 이산화티탄을 사용할 수 있으며, 상기 색소로는 식용색소, 용제로 정제수, 에탄올 등을 사용할 수 있다. The fragrance may be mixed with a suitable amount of peppermint oil, spearmint oil, menthol, anetol and the like, titanium dioxide may be used as the brightener, food coloring, purified water, ethanol, etc. may be used as the pigment. Can be.
상기 성분들을 사용하여 통상의 치약 제조방법에 따라 제조한다.The above ingredients are used to prepare a conventional toothpaste manufacturing method.
하나의 예로서, 본 발명의 구강용 조성물이 구강용 청정제 또는 구강세정제의 제형일 경우, 상기와 같은 연마제, 습윤제, 결합제, 감미제, pH 조절제, 방부제, 약효성분, 향료, 증백제, 색소, 용제 등을 함유할 수 있다. 상기 성분들을 사용하여 통상의 구강용 청정제 또는 구강세정제의 제조방법에 따라 제조한다.As an example, when the composition for oral cavity of the present invention is a formulation of a mouthwash or mouthwash, the above-described abrasives, wetting agents, binders, sweeteners, pH adjusting agents, preservatives, active ingredients, fragrances, brighteners, pigments, solvents And the like. Using the above ingredients, it is prepared according to a conventional method for preparing a mouthwash or mouthwash.
본 발명의 구강용 조성물은 잇몸 마사지 효과와 함께 소염 및 항균 활성에 의하여 구강 염증을 예방 및 완화시키는 효과가 있어, 구강질환 예방 및 치료를 통한 구강 보건 위생 증진에 크게 기여할 수 있다.The composition for oral cavity of the present invention has an effect of preventing and alleviating oral inflammation by anti-inflammatory and antimicrobial activity along with the gum massage effect, can greatly contribute to oral health hygiene through the prevention and treatment of oral diseases.
이하, 다음 실시예 및 비교예를 통하여 본 발명을 더욱 구체적으로 설명한다. 단, 이들은 본 발명의 이해를 돕기 위한 예시일 뿐, 본 발명의 범위가 이들만으로 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to the following examples and comparative examples. However, these are only illustrations for aiding understanding of the present invention, and the scope of the present invention is not limited thereto.
실시예Example 1 내지 7 및 1 to 7 and 비교예Comparative example
하기 표 1에 나타낸 바와 같은 구성비로 본 발명에 따른 구강용 조성물(실시예 1 내지 7) 및 이와 비교하기 위한 통상의 구강용, 특히 치약 조성물(비교예)을 제조하였다. Oral compositions according to the present invention (Examples 1 to 7) and conventional oral and in particular toothpaste compositions (comparative examples) were prepared for comparison with the composition ratios as shown in Table 1 below.
이의 구체적인 제조 방법은 다음과 같다. 수세미 껍질, 섬유질, 줄기, 잎, 뿌리를 건조한 후 크기가 약 1 ~ 6 ㎜가 되도록 파쇄하여 수세미오이의 절편을 제조하였으며, 이들 절편을 추가로 에탄올 또는 정제수로 추출하여 수세미오이의 추출물을 준비하였다. The specific manufacturing method thereof is as follows. After drying the scrubber bark, fibers, stems, leaves, roots and crushed to a size of about 1 ~ 6 mm to prepare a slice of the scrubber cucumber, the extract was further extracted with ethanol or purified water to prepare an extract of scrubber cucumber. .
습윤제에 결합제 및 기타 첨가제(향료, 삭카린) 등을 분산하고 연마제 등 약효성 성분을 투입하고 약 30 분간 교반한 후, 기포제와 수세미 절편, 향료 성분을 투입한 후 진공 상태에서 20 분간 교반하여 최종 제품을 수득하였다. Disperse the binder and other additives (fragrance, saccharin), etc. in the wetting agent, add an active ingredient such as an abrasive and stir for about 30 minutes, add a foaming agent, a scouring pad, and a perfume component, and then stir for 20 minutes under vacuum. A product was obtained.
효과시험예 1: 임상적 구강 염증 완화 효과 평가 Effect Test Example 1 : Evaluation of clinical oral inflammation relieving effect
상기 실시예 1 내지 7의 구강용 조성물의 구강 염증 완화 효과를 임상적으로 확인하기 위하여 구강 염증을 앓고 있는 20세에서 40세의 남여 320명을 선출하여 8개 그룹으로 나누었다. 시험 대상자들에 대하여 Loe와 Silness의 치은지수 평점기준에 따라 상하악의 변연치은과 유두치은을 대상으로 일차 구강검사를 한 후, 검사결과가 차이가 없도록 각각의 실시예 1 내지 7의 사용군과 비교예 사용군으로 나누었다. 같은 칫솔을 제공하고 습관화된 방법으로 양치를 하게 하여 3개월 경과 단계에서 하기 표 2와 같은 방법으로 점수를 기록하여 하기 표 3과 같은 결과를 얻었다.In order to clinically confirm the oral inflammation relieving effect of the composition for oral cavity of Examples 1 to 7, 320 men and women 20 to 40 years old suffering from oral inflammation were selected and divided into eight groups. After the oral examination of marginal and papillary gingiva of upper and lower jaw according to Loe and Silness gingival score criteria, the test subjects were compared with the use groups of Examples 1 to 7 so that the test results were not different. Yes divided into groups. To provide the same toothbrush and brushed in the habitual method to record the score in the same manner as in Table 2 at the stage of 3 months to obtain the results shown in Table 3.
유의성 1: 시험 시작 단계와 6 개월 경과 단계의 치은지수 t-검증 Significance 1: gingival t-valuation at the beginning of the trial and at 6 months
유의성 2: 6개월 경과 후 비교예와의 t-검증 Significance 2: t-test with Comparative Example after 6 months
상기 표 3의 결과에서 보는 바와 같이, 실시예 1 내지 7에서 제조한 구강용 조성물을 사용한 그룹의 치은지수가 통계적으로 유의미하게 감소하였으며, 비교예의 조성물과도 통계적으로 유의미한 차이를 볼 수 있었다. 이상의 결과로부터, 본 발명에 따른 구강용 조성물은 종래의 치약에 비해 구강 염증 완화 효과가 우수한 것으로 평가되었다. As shown in the results of Table 3, the gingival index of the group using the composition for oral cavity prepared in Examples 1 to 7 was statistically significantly reduced, and also statistically significant differences with the composition of the comparative example. From the above results, the composition for oral cavity according to the present invention was evaluated to be superior to the oral inflammation relieving effect compared to the conventional toothpaste.
효과시험예 2 : 잇몸 마사지에 의한 잇몸 혈류 촉진 효과 Effect Test Example 2: Gum blood flow promotion effect of the gum massage
본 발명의 구강용 조성물의 염증 완화 효과를 평가하기 위하여, LDF(Laser Doppler Flowmeter)를 이용하여 양치 전후의 잇몸 혈류량 변화를 측정함으로써, 수세미 절편의 잇몸 마사지에 의한 혈류 촉진 효과를 비교하였다. In order to evaluate the inflammatory relieving effect of the composition for oral cavity of the present invention, the blood flow promoting effect by the loofah massage of the loofah section was compared by measuring the change in the blood flow of the gum before and after brushing with a laser Doppler Flowmeter (LDF).
즉, 상기 효과시험예 1에서의 환자들을 대상으로 시험 3개월 경과 단계에서 LDF(Laser Doppler Flowmeter, Perimed System 5000)를 이용하여 잇몸 혈류량 변화를 측정하였으며, 측정된 결과로 t-검증을 하여 실시예와 비교예에서 제조한 치약 조성물의 효과의 차이를 비교하였다. 그 결과를 하기 표 4에 나타내었다. That is, the change in gum blood flow rate was measured using LDF (Laser Doppler Flowmeter, Perimed System 5000) at the stage of 3 months after the test for the patients in Effect Test Example 1, and the result was measured by t-verification. And the effect of the toothpaste composition prepared in Comparative Example was compared. The results are shown in Table 4 below.
상기 표 4에서 볼 수 있듯이, 수세미오이를 함유하는 실시예 1 내지 7의 조성물을 사용한 경우 비교예에 비하여 월등히 높은 잇몸 혈류 촉진 효과를 나타내었다. As can be seen in Table 4, the composition of Examples 1 to 7 containing scrubber cucumber showed a significantly higher gum blood flow promoting effect than the comparative example.
효과시험예 3: 치약 조성물의 안정성 비교 평가 Effect Test Example 3 Comparative Evaluation of Stability of Toothpaste Composition
실시예 및 비교예에서 제조한 치약 조성물을 각각 상온 및 40℃에서 보관하면서 다음의 기준에 따라 일정 기간 간격으로 치약 조성물의 상태 안정성을 평가하였다 The toothpaste compositions prepared in Examples and Comparative Examples were stored at room temperature and 40 ° C., respectively, and the state stability of the toothpaste compositions was evaluated at regular intervals according to the following criteria.
< 평가 기준 >Evaluation criteria
◎ 매우 양호: 표면이 매끈하고 상 분리가 없으며 변색이 없으며 정상적인 치약. ◎ Very good: smooth surface, no phase separation, no discoloration, normal toothpaste.
○ 비교적 양호: 약간의 변색이 있으며 표면만 약간 거칠거나 튜브 입구 부분만 약간 불량함. O Relatively good: slight discoloration and only slightly rough surface or slightly poor tube entrance.
∇ 비교적 불량: 상 분리 현상이 보이고 변색 현상도 나타남. ∇ relatively poor: phase separation and discoloration.
× 매우 불량: 상 분리 또는 변색이 심하고 가스 발생 혹은 경화 현상 등이 나타남. X Very poor: severe phase separation or discoloration, gas generation or hardening.
상기 표 5에서 알 수 있듯이, 실시예 1 내지 7의 본 발명에 따른 구강용 조성물은 상태 안정성에 있어서 비교예에서 제조한 조성물과 동등 수준 이상의 안정성을 확보하고 있는 것으로 평가되었다. 이러한 결과로부터, 본 발명에 따른 구강용 조성물은 종래의 시판되고 있는 잇몸 질환 예방 치약이나 충치 예방 및 프라그 제거용 치약류와 비교하여, 구강 염증 완화 효과 및 잇몸 혈류 촉진 효과가 우수하며, 안정성에 있어서도 우수함을 알 수 있었다.As can be seen from Table 5, the compositions for oral cavity according to the present invention of Examples 1 to 7 were evaluated to secure a level of stability equal to or higher than that of the composition prepared in Comparative Example in state stability. From these results, the composition for oral cavity according to the present invention is excellent in oral inflammation relieving effect and gum blood flow promoting effect, compared to the conventional gum disease prevention toothpaste, tooth decay prevention and plaque removal toothpaste, and also in stability It was found to be excellent.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080017109A KR20090091898A (en) | 2008-02-26 | 2008-02-26 | Oral compositions containing luffa cylindrica |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080017109A KR20090091898A (en) | 2008-02-26 | 2008-02-26 | Oral compositions containing luffa cylindrica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090091898A true KR20090091898A (en) | 2009-08-31 |
Family
ID=41209094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020080017109A Ceased KR20090091898A (en) | 2008-02-26 | 2008-02-26 | Oral compositions containing luffa cylindrica |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20090091898A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102445454B1 (en) * | 2022-02-21 | 2022-09-19 | 송태용 | Oriental toothpaste containing herbal medicines |
| CN115919918A (en) * | 2023-01-17 | 2023-04-07 | 广东医科大学 | Application of alcohol precipitation extract of towel gourd |
-
2008
- 2008-02-26 KR KR1020080017109A patent/KR20090091898A/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102445454B1 (en) * | 2022-02-21 | 2022-09-19 | 송태용 | Oriental toothpaste containing herbal medicines |
| CN115919918A (en) * | 2023-01-17 | 2023-04-07 | 广东医科大学 | Application of alcohol precipitation extract of towel gourd |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7592025B2 (en) | Vehicles for oral care with magnolia bark extract | |
| US20060045851A1 (en) | Oral care composition comprising essential oils | |
| AU2005316974B2 (en) | Tartar control oral care composition containing extract of magnolia | |
| KR20200012181A (en) | Toothpaste composition comprising herbal extract mixture as effective component | |
| KR101336726B1 (en) | Composition of toothpaste which contains flower fragments | |
| CN104066417B (en) | Oral care composition comprising isobutyl magnolol | |
| KR100951396B1 (en) | Toothpaste composition excellent in bad breath removal, plaque removal and antibacterial effect | |
| CN111315356A (en) | Foaming solid agent for cleaning oral cavity and preparation method thereof | |
| KR101518832B1 (en) | Oral composition for effective plaque care | |
| US5316760A (en) | Mouth-care products | |
| TWI458500B (en) | Oral health care composition and method | |
| US10813878B2 (en) | Oral health composition | |
| KR20090091898A (en) | Oral compositions containing luffa cylindrica | |
| RU2306922C2 (en) | Using of grass decoctions as water medium in producing of tooth-paste and tooth-paste composition | |
| Sohta et al. | Comprehensive Review on Herbal or Medicated Toothpaste--A Review on Herbal v/s Medicated Toothpaste | |
| KR102704053B1 (en) | Manufacturing method of toothpaste composition including ingredient of improving oral dryness | |
| EP0414788B1 (en) | Mouthcare-products | |
| KR100665891B1 (en) | Oral hygiene-containing composition containing hydroxytyrosol | |
| KR20060067295A (en) | Oral composition for preventing gum disease and preventing bad breath | |
| CN104135992B (en) | Oral care composition | |
| KR20070081613A (en) | Toothpaste composition containing only grapefruit seed extract as preservative | |
| KR20060060291A (en) | Toothpaste composition | |
| KR20200132025A (en) | Toothpaste material containing skin nano meal of paper mulberry and method for manufacturing of the same | |
| KR20060092508A (en) | Toothpaste composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20080226 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20121228 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20080226 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140328 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140929 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |